Biostar Pharmaceuticals Inc (BSPM)

0.0001 0.00 (0.00%) USD  |  OTCM  |  Apr 22, 16:00
More

Biostar Pharmaceuticals Total Liabilities (Quarterly): 5.279M for Sept. 30, 2017

Total Liabilities (Quarterly) Chart

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2007. Upgrade now.
Date Value
September 30, 2017 5.279M
June 30, 2017 5.291M
March 31, 2017 5.311M
December 31, 2016 5.623M
September 30, 2016 6.533M
June 30, 2016 6.292M
March 31, 2016 6.421M
December 31, 2015 7.098M
September 30, 2015 10.52M
June 30, 2015 9.607M
March 31, 2015 8.234M
December 31, 2014 8.912M
September 30, 2014 9.535M
June 30, 2014 9.847M
March 31, 2014 6.882M
December 31, 2013 4.792M
September 30, 2013 10.64M
June 30, 2013 10.84M
March 31, 2013 11.52M
December 31, 2012 12.70M
Date Value
September 30, 2012 4.188M
June 30, 2012 2.657M
March 31, 2012 6.496M
December 31, 2011 6.660M
September 30, 2011 11.29M
June 30, 2011 9.805M
March 31, 2011 6.459M
December 31, 2010 7.587M
September 30, 2010 5.528M
June 30, 2010 6.847M
March 31, 2010 5.555M
December 31, 2009 6.091M
September 30, 2009 4.541M
June 30, 2009 7.289M
March 31, 2009 6.178M
December 31, 2008 5.725M
September 30, 2008 4.823M
June 30, 2008 5.403M
December 31, 2007 3.955M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

American Oriental Bioengineering Inc --
Infinity Pharmaceuticals Inc 58.64M
CASI Pharmaceuticals Inc 51.10M
BIMI International Medical Inc 24.90M
Meihua International Medical Technologies Co Ltd 23.22M

Total Liabilities (Quarterly) Related Metrics

Total Assets (Quarterly) 41.43M
Shareholders Equity (Quarterly) 36.15M